IT-Diab, created in 2009 (France), from 5 sister brands and 2214 competing brands. IT-Diab is owned by Genfit, listed on the stock exchange of Paris Its International Securities Identification Number (ISIN) is FR0004163111. IT-Diab belongs to the Biotechnology business sector.
Investment simulator :
Portfolio valuation
Genfit
(IT-Diab)
over 5 years*
EUR 0.44